New study hints at the cause of a painful skin condition-and at a long-awaited potential treatment Dr. Kamal Kant Kohli26 Jun 2026 8:30 PM ISTImagine a skin condition so painful, people with it are reduced to crawling around their homes to avoid having to walk on thick and painful calluses....
Ruxolitinib Cream Provides Rapid and Sustained Relief in Atopic Dermatitis: Study Medha Baranwal25 Jun 2026 8:30 PM ISTCanada: Researchers have found in a new study that patients with atopic dermatitis (AD) treated with 1.5% ruxolitinib cream experienced rapid and...
AbbVie Acquires Apogee Therapeutics for USD 10.9 Billion to Boost Immunology Pipeline sheeba farhat23 Jun 2026 11:24 PM ISTBengaluru: AbbVie said on Monday it would buy biotech Apogee Therapeutics for USD 10.9 billion, in its largest buyout in more than five years as it...
Can diabetes and obesity drugs also help the skin? Dr. Kamal Kant Kohli23 Jun 2026 9:15 PM ISTGLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity for their effectiveness...
Maternal Type 1 Diabetes during pregnancy linked to Atopic Dermatitis Risk in Offspring: Study Jacinthlyn Sylvia14 Jun 2026 8:00 PM ISTA large population-based cohort study found that maternal type 1 diabetes mellitus (T1DM) was associated with a slightly increased prevalence of...
Scars of life: study shows impact of atopic dermatitis on educational and career choices Dr. Kamal Kant Kohli31 May 2026 8:30 PM ISTAtopic dermatitis (AD), the most common form of eczema, impacts patients' life trajectories beyond the physical scars. A novel study shows that adults...
Mount Sinai dermatologist reports Phase 3 success for rocatinlimab in moderate-to-severe eczema Dr. Kamal Kant Kohli27 May 2026 8:15 PM ISTAn international team of investigators led by Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman...
Tralokinumab Effective Across Racial Groups in Atopic Dermatitis: Phase III Analysis Medha Baranwal22 May 2026 8:15 PM ISTUSA: A post-hoc analysis of phase III clinical trials suggests that tralokinumab demonstrates consistent efficacy and a favorable safety profile in...
Atopic Dermatitis Severity tied to Sexual Health disorders, suggests study Dr Riya Dave20 April 2026 8:30 PM ISTA survey incorporating three validated sexual health scales and questions on the impact of atopic dermatitis (AD) on sexual activity found that...
American Academy of Dermatology Issues First Pediatric Atopic Dermatitis Guidelines Highlighting Prevention and Expanded Therapies Dr. Kamal Kant Kohli13 April 2026 8:15 PM ISTThe American Academy of Dermatology's first pediatric atopic dermatitis guidelines note limited evidence for most preventive interventions, with early...
Fluconazole Successfully Treats Dupilumab-Associated Palmar Erythema: Case Report Medha Baranwal8 April 2026 8:15 PM ISTAustralia: A clinical letter published in the Australasian Journal of Dermatology highlights a potential treatment approach for a lesser-known side...
GLP-1 Receptor Agonists Reduce Cardiovascular Risk Among Atopic Dermatitis Patients, Suggests Study Medha Baranwal5 April 2026 8:15 PM ISTUSA: Researchers have found in a new study that patients with atopic dermatitis who used GLP-1 receptor agonists showed a lower long-term risk of...
